Publication
Genital HIV-1 Shedding With Dolutegravir (DTG) Plus Lamivudine (3TC) Dual Therapy
Downloadable Content
- Persistent URL
- Last modified
- 05/14/2025
- Type of Material
- Authors
- Language
- English
- Date
- 2018-12-15
- Publisher
- Lippincott, Williams & Wilkins
- Publication Version
- Copyright Statement
- Copyright © 2018 Wolters Kluwer Health, Inc. All rights reserved.
- Final Published Version (URL)
- Title of Journal or Parent Work
- ISSN
- 1525-4135
- Volume
- 79
- Issue
- 5
- Start Page
- E112
- End Page
- E114
- Grant/Funding Information
- ViiV Healthcare/GlaxoSmithKline provided funding and study drugs.
- This work was supported by an Investigator Sponsored Study grant “Virologic Activity of DTG +3TC in the Genital Compartment: Substudy of ASPIRE and A5353” from ViiV Healthcare to Northwestern University.
- Additional support was provided from the National Institute of Allergy and Infectious Diseases of the National Institutes of Health under Award Number UM1 AI068634, UM1 AI068636 and UM1 AI106701; the San Diego Center for AIDS Research Translational Virology Core (P30AI036214); as well as the Third Coast Center for AIDS Research (P30AI117943); and Emory Center for AIDS Research (P30AI050409).
- Supplemental Material (URL)
- Author Notes
- Keywords
- Research Categories
- Biology, Virology
- Health Sciences, Medicine and Surgery
Tools
- Download Item
- Contact Us
-
Citation Management Tools
Relations
- In Collection:
Items
| Thumbnail | Title | File Description | Date Uploaded | Visibility | Actions |
|---|---|---|---|---|---|
|
|
Publication File - v74zm.pdf | Primary Content | 2025-04-08 | Public | Download |